Thalassemia: Types, Causes, Diagnosis, and Treatment:
Introduction to Thalassemia
Thalassemia is a genetic blood disorder that affects the body’s ability to produce hemoglobin and red blood cells. Hemoglobin is the iron-rich protein in red blood cells responsible for carrying oxygen throughout the body. When hemoglobin production is defective or insufficient, it leads to anemia, a condition where the body doesn’t get enough oxygen-rich blood.
Thalassemia can range from mild to severe and may require ongoing medical treatment or lifelong blood transfusions, depending on the type and severity.
What Is Thalassemia?
Thalassemia is classified as an inherited disorder, meaning it is passed down from parents to children through genes. Individuals with thalassemia have mutations in the HBB gene that codes for hemoglobin production.
When the genes responsible for hemoglobin production are altered, the body produces fewer healthy red blood cells, resulting in chronic anemia.
Types of Thalassemia
Thalassemia is mainly categorized based on which part of the hemoglobin molecule is affected:
1. Alpha Thalassemia
Alpha thalassemia occurs when there’s a defect in one or more of the four alpha-globin genes located on chromosome 16.
• Silent Carrier (1 gene mutation): Usually no symptoms.
• Alpha Thalassemia Trait (2 gene mutations): Mild anemia.
• Hemoglobin H Disease (3 gene mutations): Moderate to severe anemia.
• Hydrops Fetalis (4 gene mutations): A severe condition causing stillbirth or death shortly after birth.
2. Beta Thalassemia
• Beta thalassemia occurs when there are mutations in the beta-globin genes on chromosome 11.
• Beta Thalassemia Minor (Trait): One defective gene; mild or no symptoms.
• Beta Thalassemia Intermedia: Two defective genes; moderate symptoms, may not need regular transfusions.
• Beta Thalassemia Major (Cooley’s Anemia): Two defective genes; severe anemia, requires lifelong transfusions.
Causes of Thalassemia
Thalassemia is caused by mutations in the DNA of cells that make hemoglobin. These genetic mutations are inherited from one or both parents.
Inheritance Patterns
If one parent carries the gene: The child may develop thalassemia minor (carrier).
If both parents carry the gene: The child has a 25% chance of developing thalassemia major or a more severe form.
Risk Factors
Family History: The strongest risk factor.
Ethnic Background: More common in people of Mediterranean, Middle Eastern, African, South Asian, and Southeast Asian descent.
Consanguineous Marriage: Increases the risk of passing on genetic disorders.
Symptoms of Thalassemia
Symptoms depend on the type and severity. Some individuals may be asymptomatic, especially those with minor thalassemia.
Common Signs and Symptoms
• Fatigue and weakness
• Pale or yellowish skin
• Facial bone deformities (in severe cases)
• Slow growth in children
• Dark urine
• Enlarged spleen (splenomegaly)
• Shortness of breath
• Severe Symptoms (Thalassemia Major)
• Failure to thrive in infancy
• Severe anemia
• Frequent infections
• Skeletal abnormalities
• Heart complications
• How Is Thalassemia Diagnosed?
1. Blood Tests
Complete Blood Count (CBC): Detects anemia and microcytosis (small red blood cells).
Hemoglobin Electrophoresis: Identifies abnormal hemoglobin types.
Iron Studies: Helps distinguish thalassemia from iron-deficiency anemia.
2. Genetic Testing
Detects mutations in globin genes.
Essential for carrier screening and prenatal diagnosis.
3. Prenatal Testing
Chorionic Villus Sampling (CVS): Done around the 10th–12th week of pregnancy.
Amniocentesis: Conducted during the 15th–20th week.
Helps parents make informed reproductive choices.
Treatment of Thalassemia
The treatment depends on the type and severity of the disease. Mild forms may require minimal or no intervention, while severe forms need regular medical care.
1. Blood Transfusions
• Regular red blood cell transfusions are the cornerstone of treatment in severe thalassemia.
• Frequency may range from every 2–4 weeks.
2. Iron Chelation Therapy
•. Frequent transfusions lead to iron overload, damaging organs.
• Deferoxamine (Desferal): Injectable chelator.
• Deferasirox (Exjade): Oral chelator.
• Prevents complications like heart and liver damage.
3. Folic Acid Supplements
Folic acid helps red blood cell production. Recommended for those with chronic anemia.
4. Bone Marrow or Stem Cell Transplant
• Only curative treatment available.
• Most successful in young patients with a matched donor.
• High-risk procedure but offers long-term relief.
5. Gene Therapy (Emerging)
• Aims to correct the faulty gene.
• Still under clinical trials but shows promising results for beta-thalassemia.
Complications of Thalassemia
• Without proper management, thalassemia can lead to:
• Heart problems (arrhythmias, heart failure)
• Liver disease
• Delayed puberty and growth
• Bone deformities
• Gallstones
• Increased infection risk
Thalassemia and Pregnancy
• Women with thalassemia need specialized care during pregnancy.
• May experience fertility issues.
• Requires close monitoring, transfusions, and iron levels management.
• Genetic counseling is crucial before conception.
Living with Thalassemia
Lifestyle and Self-Care
• Eat a balanced diet rich in calcium and low in iron (unless prescribed).
• Avoid iron supplements unless advised.
• Get regular vaccinations to prevent infections.
• Regular follow-ups with a hematologist.
Psychological and Social Support
Coping with a chronic illness can be emotionally challenging.
Support groups and counseling help improve mental health and quality of life.
Preventing Thalassemia
Thalassemia cannot be prevented after birth, but steps can reduce the risk in future generations.
1. Genetic Counseling
Couples with a family history or from high-risk ethnic groups should consider carrier screening before marriage or pregnancy.
2. Prenatal Screening
• Early detection through fetal DNA testing or amniocentesis.
• Helps make informed decisions.
Global Prevalence of Thalassemia
• WHO estimates that 5–7% of the global population are carriers.
• India alone has over 100,000 patients and about 10,000 new cases yearly.
• Most common in countries around the Mediterranean, South Asia, and Middle East.
Government and NGO Initiatives
• Many countries have launched national thalassemia control programs that include:
• Free or subsidized blood transfusions
• Carrier screening in schools and colleges
• Public awareness campaigns
• Support for genetic counseling centers
Future of Thalassemia Treatment
With advancements in gene editing technologies like CRISPR, the future looks hopeful for a permanent cure. Gene therapy has already shown success in clinical trials, offering a potentially one-time treatment.
Conclusion
Thalassemia is a serious but manageable genetic blood disorder. Early diagnosis, consistent treatment, and genetic counseling can help individuals lead fulfilling lives. As science advances, new treatment options like gene therapy may revolutionize thalassemia care and potentially eliminate the disease in the future.
If you or your loved one is diagnosed with thalassemia, stay informed, consult experienced medical professionals, and join support networks to manage the condition effectively.
I hope that you liked this article.
Thanks!! 🙏 😊
Writer: Vandita Singh, Lucknow (GS India Nursing Group)